Table 3.
Mean EQ-5D scores, health visual analogue scale (VAS) scores, and Minnesota living with health failure questionnaire (MLHFQ) scores for groups at baseline and at three months' and six months' follow-up
| Intervention group | Control group | Adjusted mean difference (95% CI); P value* | ||||
|---|---|---|---|---|---|---|
| Score (SD) | No of respondents | Score (SD) | No of respondents | |||
| EQ-5D at baseline† | 0.58 (0.32) | 147 | 0.57 (0.34) | 144 | ||
| EQ-5D at 3 months† | 0.54 (0.33) | 113 | 0.51 (0.37) | 100 | ||
| EQ-5D at 6 months† | 0.58 (0.29) | 108 | 0.52 (0.34) | 104 | 0.07 (−0.01 to 0.14); P=0.08 | |
| VAS at baseline† | 56.6 (19.0) | 143 | 56.9 (19.6) | 140 | ||
| VAS at 3 months† | 58.4 (20.8) | 107 | 52.9 (21.9) | 96 | ||
| VAS at 6 months† | 58.2 (19.6) | 105 | 58.6 (19.8) | 102 | −0.93 (−6.05 to 4.20); P=0.72 | |
| MLHFQ at baseline‡ | 45.9 (24.4) | 139 | 46.1 (23.9) | 136 | ||
| MLHFQ at 3 months‡ | 49.6 (28.4) | 85 | 54.4 (26.4) | 71 | ||
| MLHFQ at 6 months‡ | 47.7 (26.3) | 78 | 44.5 (27.9) | 80 | 3.73 (−3.67 to 11.13); P=0.32 | |
*Based on analysis of covariance comparing results at six months adjusted for baseline score, site, and New York Heart Association class.
†High scores imply better health.
‡Low scores imply better health.